СПОСОБ ОБНАРУЖЕНИЯ ПРЕДРАСПОЛОЖЕННОСТИ К КАРДИОВАСКУЛЯРНОМУ ЗАБОЛЕВАНИЮ

摘要

Includes the identification in the genetic material of an isolated biological sample from said human an allelic variant which consist on the substitution of a cytosine by an tymine in the position 46 over the transcriptional origin of Factor XII (46C/T) within the locus of chromosome 5, limited by the D5S400 and D5S408 markers, being the presence of said allelic variant is indicative of a predisposition to a cardiovascular disease. In said process, use is made of a biological sample susceptible of including at least one allelic variant within the chromosome 5 locus limited by the D5S400 and D5S408 markers in order to determine a predisposition to cardiovascular diseases which manifest with thrombotic events. The process permits detection of a predisposition to a cardiovascular disease in a human, so that a suitable preventive an therapeutic strategy can be designed.